Low IP-10/CXCL10 Levels are Associated with Good Responses to Lenalidomide Plus Low-Dose Dexamethasone for Relapsed and/or Refractory Multiple Myeloma
Saved in:
Published in | Clinical lymphoma, myeloma and leukemia Vol. 18; p. S237 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.09.2018
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 2152-2650 |
---|---|
DOI: | 10.1016/j.clml.2018.07.124 |